Q522--PHARMACUTICAL, STL 657-24-3-1642-0121, (VA-25-00001168)
ID: 36C25524Q0422Type: Sources Sought
Overview

Buyer

VETERANS AFFAIRS, DEPARTMENT OFVETERANS AFFAIRS, DEPARTMENT OF255-NETWORK CONTRACT OFFICE 15 (36C255)LEAVENWORTH, KS, 66048, USA

NAICS

Pharmaceutical Preparation Manufacturing (325412)

PSC

MEDICAL- RADIOLOGY (Q522)

Original Source

https://sam.gov/opp/9ab2791166ea463b889780de64d554b3/view
Timeline
    Description

    The Department of Veterans Affairs is seeking responses to a Sources Sought Notice for a contract involving the provision of a proprietary radiopharmaceutical agent, Pluvicto, for the St. Louis VA Medical Center. This contract will cover a base year plus four option years for the supply of Lutetium LU 177 Vipivvotide Tetraxetan, which is critical for treating adult patients with prostate-specific membrane antigen (PSMA) positive metastatic castration-resistant prostate cancer. The selected contractor will be responsible for administering this radioactive diagnostic therapy via IV, with all contract administration functions retained by the Department of Veterans Affairs. Interested parties must submit their responses by September 20, 2024, at 3:00 PM CST, to Michael P. Murphy at michael.murphy7@va.gov, including their Unique Entity ID and relevant qualifications.

    Point(s) of Contact
    Michael P MurphySenior Contract Specialist
    (913) 946-1963
    michael.murphy7@va.gov
    Files
    Title
    Posted
    _rels/.rels
    [Content_Types].xml
    docProps/app.xml
    docProps/core.xml
    word/_rels/document.xml.rels
    word/document.xml
    word/fontTable.xml
    word/footer1.xml
    word/footer2.xml
    word/header1.xml
    word/header2.xml
    word/settings.xml
    word/styles.xml
    word/theme/theme1.xml
    word/webSettings.xml
    Lifecycle
    Title
    Type
    Q522--PHARMACUTICAL, STL 657-24-3-1642-0121, (VA-25-00001168)
    Currently viewing
    Sources Sought
    Similar Opportunities
    6505--Notice of Intent to Sole Source Pluvicto and Lutathera
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs (VA) intends to award a sole source contract to Advanced Accelerator Applications USA for the provision of Pluvicto and Lutathera, specialized radiopharmaceuticals used in the treatment of metastatic castration-resistant prostate cancer and gastroenteropancreatic neuroendocrine tumors. This procurement is justified under FAR regulations due to the unique and highly specialized nature of the therapies required, which limits the availability of suitable suppliers. Interested parties are invited to submit their capability statements, including qualifications and relevant contract information, by 10:00 AM PT on September 25, 2024, to Peter Kim at peter.kim33@va.gov. The contracting office is located in Long Beach, CA, and responses must be submitted electronically; failure to respond may result in the contract being awarded without further solicitation.
    6505--Radiopharmaceuticals for nuclear medicine VA patients
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs is seeking proposals for an Indefinite Delivery Indefinite Quantity (IDIQ) contract to supply radiopharmaceuticals for nuclear medicine patients at the Boise VA Medical Center. The procurement aims to ensure the availability of various nuclear medicine supplies over a five-year period, starting November 1, 2024, with requirements for 24/7 availability and emergency deliveries within 90 minutes for urgent orders. This initiative is crucial for providing high-quality medical treatment to VA patients, emphasizing compliance with federal regulations and timely service delivery. Interested parties must submit their proposals by October 3, 2024, at 1:00 PM Pacific Time, and can direct inquiries to Jose E Ronstadt at jose.ronstadt@va.gov or by phone at 360-852-9885.
    6505--Ga68 PSMA Injection (Illucix)
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs is seeking a contractor to provide Gallium Ga68 (Ga68-PSMA; Illucix®) radiopharmaceutical injections for the VA North Texas Health Care System, with a focus on PET imaging of prostate cancer lesions. The procurement requires contractors to possess a valid license from the US Nuclear Regulatory Commission and adhere to federal and state regulations regarding the handling and transportation of radioactive materials, ensuring safe and efficient delivery of essential medical supplies. Interested parties must submit their quotations by October 8, 2024, at 3:00 PM CST, to the designated Contract Specialist, Vance Farrell, via email, with the anticipated delivery period set from October 25, 2024, to October 24, 2025.
    6505--Supply, Axumin-Axumin + Cerianna Medicines - Nuclear Med, CLE
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs intends to solicit and negotiate exclusively with PetNet Solutions and TrillaMed for the supply of three proprietary radiopharmaceuticals—Axumin, Amyvid, and Cerianna—for the Nuclear Medicine Service at the Louis Stokes Cleveland VA Medical Center. These products are critical for diagnosing recurrent prostate cancer, breast cancer, and Alzheimer’s disease, necessitating the use of a local radiopharmacy due to their radioactive nature and short shelf life. Interested vendors may submit their capabilities until September 18, 2024, to determine if a competitive procurement process is feasible, with all inquiries directed to Contract Specialist Don Caldwell at don.caldwell@va.gov.
    6505--Lymphoseek IDIQ
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs, specifically the Network Contracting Office 22, intends to award a Sole Source contract for the procurement of Lymphoseek, a proprietary radiopharmaceutical, primarily for use at the VA Loma Linda Healthcare System. This contract, designated as Solicitation Number 36C26225Q0026, will be structured as a Firm Fixed-Price Indefinite Quantity Indefinite Delivery (IDIQ) with a base year and four option years, with an estimated quantity of 86 study doses required annually. Lymphoseek is critical for identifying sentinel lymph nodes in melanoma patients, providing superior image quality due to its targeted action on the CD206 receptor. Interested parties may submit a capabilities statement by September 27, 2024, at 10:00 AM Pacific Time, and should direct inquiries to Hestia Sim at Hestia.Sim@va.gov.
    Q527--Intent to Sole Source Radiopharm Isotopes-Wilkes-Barre VAMC
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs, through Network Contracting Office 4, intends to issue a sole source contract for the provision of Radiopharmaceutical Isotopes to the Wilkes-Barre VA Medical Center, specifically with Jubilant Draximage Radiopharmaceuticals Inc. The contract aims to ensure the timely delivery of radiopharmaceuticals that comply with U.S. Nuclear Regulatory Commission (NRC) and Food and Drug Administration (FDA) regulations, thereby prioritizing patient safety and effective healthcare for veterans. This procurement is critical for maintaining high-quality medical services, as the contractor will be required to adhere to strict quality control measures, provide emergency services, and ensure proper packaging and labeling of all materials supplied. Interested vendors must submit a capability statement by September 20, 2024, to the Contracting Specialist, Christa Stine, at christa.stine@va.gov.
    6640--BD MAX REAGENTS STL
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs is seeking qualified vendors to provide molecular testing and extraction supplies for the BD MAX instrument at the St. Louis VA Medical Center. This procurement involves a Firm Fixed Price Blanket Purchase Agreement (BPA) for specific reagents necessary for nucleic acid detection and extraction, with an estimated contract duration of one base year and four optional yearly ordering periods, commencing from November 1, 2024, to October 31, 2029. The supplies are critical for ensuring uninterrupted patient care operations, and interested parties, particularly Service-Disabled Veteran Owned Small Businesses, must submit their responses by September 20, 2024, to Contract Specialist Michael P. Murphy at michael.murphy7@va.gov. The government does not guarantee any contract awards based on this notice, which serves solely for market research purposes.
    Q517--Hazardous Compounding
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs is seeking proposals for hazardous compounding services to support the Gulf Coast Veterans Health Care System, specifically for providing compounded hazardous chemotherapy agents at its facilities in Biloxi, MS, and Pensacola, FL. The contract will be structured as a firm-fixed price, indefinite-delivery, indefinite-quantity agreement, with a base period from October 1, 2024, to September 30, 2025, and the option for four additional one-year extensions. This procurement is critical for ensuring the timely and compliant delivery of essential medical treatments to veterans, adhering to FDA and USP standards while emphasizing quality assurance and regulatory compliance. Interested contractors should submit their proposals and past performance questionnaires by 12 PM CT on September 20, 2024, and can direct inquiries to Contracting Officer Tina L. Harris at Tina.Harris3@va.gov.
    DA10--MIM Software
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs (VA) is seeking contractors to provide MIM software for the Overton Brooks VA Medical Center's radiation oncology department. The procurement aims to enhance patient treatment planning and care through advanced software features, including segmentation, dose accumulation, and seamless integration with existing treatment planning systems. This initiative is crucial for improving cancer treatment for veterans, with a project duration of five years, comprising a base year and four optional years. Interested contractors must submit their qualifications, including business size and status, by September 20, 2024, to the Contract Specialist, Emilio Ballentos, at emilio.ballentos@va.gov.
    QA software and equipment for radiotherapy beam dosimetry systems
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs (VA) is seeking qualified contractors to provide Quality Assurance (QA) software and equipment for radiotherapy beam dosimetry systems, specifically authorized distributors of Sun Nuclear equipment. The procurement includes three specific packages: the Sun Nuclear Dosimetry Package, Patient Quality Management Package, and Machine Quality Management Package, all of which are essential for ensuring quality management in radiotherapy. This Sources Sought Notice aims to identify potential contractors and is part of the VA's Veterans First Contracting Program, which prioritizes contracts for Service-Disabled Veteran-Owned Small Businesses (SDVOSBs) and Veteran-Owned Small Businesses (VOSBs). Interested parties must respond by September 16, 2024, and can contact Robert Bleichner at robert.bleichner@va.gov for further information.